History
Insmed has evolved significantly over the years, but one thing that has remained unchanged is our commitment to patients. As we look toward the future, we are inspired by our vision to deliver life-altering therapies to small patient populations experiencing big health problems. Read on to learn more about some of the key moments that have shaped who Insmed is today.
1988
Insmed is founded as a private company by Dr. Joseph Larner in Charlottesville, Va., to develop medicines to treat diabetes.
1997
Transave is founded as a private company by Dr. Frank Pilkiewicz in Monmouth Junction, NJ, to develop inhaled pharmaceuticals for the treatment of lung diseases.
1999-2000
Insmed is incorporated in the Commonwealth of Virginia and becomes a public company (INSM) after acquiring Celtrix Pharmaceuticals in a reverse merger.
2000
Transave pioneers the early development of an inhaled liposomal antibiotic, an advancement that will later enable the approval of the Company’s first therapy.
2010
Insmed enters into a business combination with Transave, acquiring its late-stage candidate. The new company maintains the name Insmed.
2013
Insmed receives Orphan Drug Designation, Qualified Infectious Disease Product designation, and Fast Track status for its lead product candidate.
2016
Insmed enters into a worldwide license agreement with AstraZeneca for a product candidate, expanding the company’s rare disease pipeline.
2016
Insmed opens an office in Utrecht, Netherlands, further expanding its presence to Europe.
2018
Insmed submits a New Drug Application to the FDA for its lead product candidate.
2018
Insmed is granted accelerated approval by the FDA for its first therapy.
2019
Insmed opens an office in Tokyo, expanding its global presence to Japan.
2019
Insmed opens its new, state-of-the-art global headquarters in Bridgewater, NJ, to support the Company’s continued growth.
2020
Insmed reports positive data for its Phase 2 product candidate and announces plans to advance to Phase 3 development.
Insmed History Wall
An installation at Insmed’s global headquarters honors the Company’s past as we look toward the future. From the early days of the two original companies that formed Insmed to the FDA approval and launch of our first therapy, the wall highlights some of the most significant moments in Insmed’s history and showcases the values that we live every day.
Contact Us
